133 related articles for article (PubMed ID: 19109827)
1. Membrane androgen receptor activation in prostate and breast tumor cells: molecular signaling and clinical impact.
Papadopoulou N; Papakonstanti EA; Kallergi G; Alevizopoulos K; Stournaras C
IUBMB Life; 2009 Jan; 61(1):56-61. PubMed ID: 19109827
[TBL] [Abstract][Full Text] [Related]
2. Membrane-initiated steroid action in breast and prostate cancer.
Kampa M; Pelekanou V; Castanas E
Steroids; 2008 Oct; 73(9-10):953-60. PubMed ID: 18249430
[TBL] [Abstract][Full Text] [Related]
3. Rapid membrane effect of testosterone in LNCaP cells.
Wang Z; Liu L; Hou J; Wen D; Yan C; Pu J; Ouyang J; Pan H
Urol Int; 2008; 81(3):353-9. PubMed ID: 18931557
[TBL] [Abstract][Full Text] [Related]
4. Targeting membrane androgen receptors in tumors.
Lang F; Alevizopoulos K; Stournaras C
Expert Opin Ther Targets; 2013 Aug; 17(8):951-63. PubMed ID: 23746222
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle regulator cdk2ap1 inhibits prostate cancer cell growth and modifies androgen-responsive pathway function.
Zolochevska O; Figueiredo ML
Prostate; 2009 Oct; 69(14):1586-97. PubMed ID: 19585490
[TBL] [Abstract][Full Text] [Related]
6. Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis.
Kampa M; Nifli AP; Charalampopoulos I; Alexaki VI; Theodoropoulos PA; Stathopoulos EN; Gravanis A; Castanas E
Exp Cell Res; 2005 Jul; 307(1):41-51. PubMed ID: 15922725
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of SGK1 enhances mAR-induced apoptosis in MCF-7 breast cancer cells.
Liu G; Honisch S; Liu G; Schmidt S; Pantelakos S; Alkahtani S; Toulany M; Lang F; Stournaras C
Cancer Biol Ther; 2015; 16(1):52-9. PubMed ID: 25427201
[TBL] [Abstract][Full Text] [Related]
9. Membrane rafts as potential sites of nongenomic hormonal signaling in prostate cancer.
Freeman MR; Cinar B; Lu ML
Trends Endocrinol Metab; 2005 Aug; 16(6):273-9. PubMed ID: 16002302
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of prostate cancer cell survival after inhibition of AR expression.
Cohen MB; Rokhlin OW
J Cell Biochem; 2009 Feb; 106(3):363-71. PubMed ID: 19115258
[TBL] [Abstract][Full Text] [Related]
11. Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo.
Hatzoglou A; Kampa M; Kogia C; Charalampopoulos I; Theodoropoulos PA; Anezinis P; Dambaki C; Papakonstanti EA; Stathopoulos EN; Stournaras C; Gravanis A; Castanas E
J Clin Endocrinol Metab; 2005 Feb; 90(2):893-903. PubMed ID: 15585562
[TBL] [Abstract][Full Text] [Related]
12. [The filamin in cell signaling].
Komaletdinova FM; Pinaev GP
Tsitologiia; 2006; 48(11):924-34. PubMed ID: 17233478
[TBL] [Abstract][Full Text] [Related]
13. WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics.
Bisson I; Prowse DM
Cell Res; 2009 Jun; 19(6):683-97. PubMed ID: 19365403
[TBL] [Abstract][Full Text] [Related]
14. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
Vis AN; Schröder FH
BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
[TBL] [Abstract][Full Text] [Related]
15. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.
Peters AA; Buchanan G; Ricciardelli C; Bianco-Miotto T; Centenera MM; Harris JM; Jindal S; Segara D; Jia L; Moore NL; Henshall SM; Birrell SN; Coetzee GA; Sutherland RL; Butler LM; Tilley WD
Cancer Res; 2009 Aug; 69(15):6131-40. PubMed ID: 19638585
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of androgen receptor action.
Li J; Al-Azzawi F
Maturitas; 2009 Jun; 63(2):142-8. PubMed ID: 19372015
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer.
Ni J; Mai T; Pang ST; Haque I; Huang K; DiMaggio MA; Xie S; James NS; Kasi D; Chemler SR; Yeh S
Clin Cancer Res; 2009 Feb; 15(3):898-906. PubMed ID: 19188160
[TBL] [Abstract][Full Text] [Related]
19. Regulation of PSA secretion and survival signaling by calcium-independent phopholipase A(2)beta in prostate cancer cells.
Nicotera TM; Schuster DP; Bourhim M; Chadha K; Klaich G; Corral DA
Prostate; 2009 Sep; 69(12):1270-80. PubMed ID: 19475654
[TBL] [Abstract][Full Text] [Related]
20. Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth.
Takayama K; Tsutsumi S; Suzuki T; Horie-Inoue K; Ikeda K; Kaneshiro K; Fujimura T; Kumagai J; Urano T; Sakaki Y; Shirahige K; Sasano H; Takahashi S; Kitamura T; Ouchi Y; Aburatani H; Inoue S
Cancer Res; 2009 Jan; 69(1):137-42. PubMed ID: 19117996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
